Corporate ActionAug 4, 2026, 06:07 AM
ABVC BioPharma Postpones BioKey Share Distribution for Administrative Review
AI Summary
ABVC BioPharma, Inc. announced the postponement of its previously scheduled distribution of ordinary shares of BioKey (Cayman), Inc., which was set for August 3, 2026. This delay is to allow the company additional time to finalize administrative, regulatory, and tax-related matters essential for the distribution. While the record date and distribution ratio of 0.169464 BioKey shares per ABVC common stock remain unchanged, the ex-dividend date will be revised and announced once new distribution dates are finalized.
Key Highlights
- ABVC BioPharma postponed the distribution of BioKey (Cayman) Inc. ordinary shares.
- Postponement allows time to complete administrative, regulatory, and tax-related matters.
- Company is coordinating with Nasdaq, DTC, and its transfer agent for revised distribution mechanics.
- The previously announced record date for the distribution remains unchanged.
- Distribution ratio of 0.169464 BioKey shares per ABVC common stock remains the same.
- The ex-dividend date will be revised and announced with the new distribution date.
Price Impact
More from ABVC